STASIS - I, II AND III; SERATHAN - A, B; INTRIN - EA, SI CALCIUM CHLORIDE 0.02M; FIBRINOGEN CONTROL-NORMAL, LOW— 510(k) K060968
Substantially EquivalentWortham Laboratories, Inc.
FDA 510(k) clearance K060968 for STASIS - I, II AND III; SERATHAN - A, B; INTRIN - EA, SI CALCIUM CHLORIDE 0.02M; FIBRINOGEN CONTROL-NORMAL, LOW, Substantially Equivalent on 2007-05-15. Applicant: Wortham Laboratories, Inc..
Clearance details
- Applicant
- Wortham Laboratories, Inc.
- Product code
- Code GIZ
- Advisory panel
- Hematology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Chattanooga, TN, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.